Lipid-Lowering Therapy Utilization and Dosage Among Patients with Acute Coronary Syndrome Events: A Retrospective Cohort from 12 Community Hospitals

References

• Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36:1163–1170. doi:10.1093/eurheartj/ehu505
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Corra U, Dendale P, et al. Challenges in secondary prevention after acute myocardial infarction: a call for action. Eur Heart J Acute Cardiovasc Care. 2017;6:299–310. doi:10.1177/2048872616689773
   PubMed Web of Science ®Google Scholar
• Lewis SJ. Lipid-lowering therapy: who can benefit? Vasc Health Risk Manag. 2011;7:525–534. doi:10.2147/VHRM.S23113
   PubMedGoogle Scholar
• Hickson RP, Robinson JG, Annis IE, et al. Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists. J Am Heart Assoc. 2017;6:54.
   Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med. 2014;160:339–343. doi:10.7326/M14-0126
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Emberson J; Cholesterol Treatment Trialists C. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–1681.
   PubMed Web of Science ®Google Scholar
• Goff DC, Lloyd-Jones DM, Bennett G; American College of Cardiology/American Heart Association Task Force on Practice G. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49–73. doi:10.1161/01.cir.0000437741.48606.98
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ; Guideline Writing Committee for the Cholesterol G. 2018 Cholesterol Clinical Practice Guidelines: synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline. Ann Intern Med. 2019;170:779–783. doi:10.7326/M19-0365
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA. 2004;292:1307–1316. doi:10.1001/jama.292.11.1307
   PubMed Web of Science ®Google Scholar
• Cannon CP, Braunwald E, McCabe CH, et al. Pravastatin or Atorvastatin E and Infection Therapy-Thrombolysis in Myocardial Infarction I. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–1504. doi:10.1056/NEJMoa040583
   PubMed Web of Science ®Google Scholar
• Hirsh BJ, Smilowitz NR, Rosenson RS, Fuster V, Sperling LS. Utilization of and Adherence to Guideline-Recommended Lipid-Lowering Therapy After Acute Coronary Syndrome: opportunities for Improvement. J Am Coll Cardiol. 2015;66:184–192. doi:10.1016/j.jacc.2015.05.030
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73:e285–e350. doi:10.1016/j.jacc.2018.11.003
   PubMed Web of Science ®Google Scholar
• Koskinas KC, Siontis GCM, Piccolo R, et al. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials. Eur Heart J. 2018;39:1172–1180. doi:10.1093/eurheartj/ehx566
   PubMed Web of Science ®Google Scholar
• Arnold SV, de Lemos JA, Liu Y, et al. Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction. JAMA Netw Open. 2020;3:e203032. doi:10.1001/jamanetworkopen.2020.3032
   PubMed Web of Science ®Google Scholar
• Wang WT, Hellkamp A, Doll JA, et al. Lipid Testing and Statin Dosing After Acute Myocardial Infarction. J Am Heart Assoc. 2018;7:67.
   Google Scholar
• Rosenson RS, Farkouh ME, Mefford M, et al. Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014. J Am Coll Cardiol. 2017;69:2696–2706. doi:10.1016/j.jacc.2017.03.585
   PubMedGoogle Scholar
• Peters SAE, Colantonio LD, Zhao H, et al. Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States. J Am Coll Cardiol. 2018;71:1729–1737. doi:10.1016/j.jacc.2018.02.032
   PubMedGoogle Scholar
• Graham GN, Jones PG, Chan PS, Arnold SV, Krumholz HM, Spertus JA. Racial Disparities in Patient Characteristics and Survival After Acute Myocardial Infarction. JAMA Netw Open. 2018;1:e184240. doi:10.1001/jamanetworkopen.2018.4240
   PubMed Web of Science ®Google Scholar
• Graham G. Racial and Ethnic Differences in Acute Coronary Syndrome and Myocardial Infarction Within the United States: from Demographics to Outcomes. Clin Cardiol. 2016;39:299–306. doi:10.1002/clc.22524
   PubMed Web of Science ®Google Scholar
• Kim EJ, Kressin NR, Paasche-Orlow MK, et al. Racial/ethnic disparities among Asian Americans in inpatient acute myocardial infarction mortality in the United States. BMC Health Serv Res. 2018;18:370. doi:10.1186/s12913-018-3180-0
   PubMed Web of Science ®Google Scholar
• Chi GC, Kanter MH, Li BH, et al. Trends in Acute Myocardial Infarction by Race and Ethnicity. J Am Heart Assoc. 2020;9:e013542. doi:10.1161/JAHA.119.013542
   PubMedGoogle Scholar
• Arora S, Stouffer GA, Kucharska-Newton A, et al. Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: the ARIC Community Surveillance Study, 2000-2014. J Am Heart Assoc. 2018;7:e010203. doi:10.1161/JAHA.118.010203
   PubMed Web of Science ®Google Scholar
• Bradley CK, Wang TY, Li S, et al. Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: insights From the PALM Registry. J Am Heart Assoc. 2019;8:e011765. doi:10.1161/JAHA.118.011765
   PubMed Web of Science ®Google Scholar
• Branda ME, LeBlanc A, Shah ND, et al. Shared decision making for patients with type 2 diabetes: a randomized trial in primary care. BMC Health Serv Res. 2013;13:301. doi:10.1186/1472-6963-13-301
   PubMed Web of Science ®Google Scholar
• Levintow SN, Reading SR, Noshad S, Mayer SE, Wiener C, Eledath B. Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008-2019. Clin Epidemiol. 2022;14:737–748. doi:10.2147/CLEP.S361258
   PubMed Web of Science ®Google Scholar